rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,13:47
1495.00
9.85 (0.66%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
64,076 1,485.15 1,506.75 - 1,470.05 1,581.70 - 1,028.00 120,736.21
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,13:47
1495.40
9.90 (0.67%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
837,479 1485.5 1,507.05 - 1,470.65 1,582.00 - 1,027.00 12,514.62

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03
Farm Policy...
Farm Policy Re-orientation: CEA Nageswaran's Call
CEA Nageswaran advocates for a pan-India dialogue on agriculture, urging policy re-orientation despite subsidies, to address challenges like soil degradation and environmental pollution.
Jul 22, 2024 13:56
Coal India Wins...
Coal India Wins First Critical Mineral Asset: Graphite Block
Coal India has secured its first critical mineral asset, a graphite block in Madhya Pradesh, marking its entry into non-coal mineral mining. The move supports the country's green energy transition...
Jul 22, 2024 13:50
Education Quality...
Education Quality Improvement: Centre & States Need to Converge
India's Economic Survey highlights the need for collaborative efforts between the Centre and states to enhance education quality, particularly in primary education, to achieve foundational literacy...
Jul 22, 2024 13:48

More News »

Top News

Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03
Telecom R&D: Govt Allocates 5% of USOF for Tech Development
India's Economic Survey 2023-24 announces allocation of 5% of USOF for telecom R&D, aiming to boost technology innovation and development of 5G and 6G services.
Jul 22, 2024 13:57
Farm Policy...
Farm Policy Re-orientation: CEA Nageswaran's Call
CEA Nageswaran advocates for a pan-India dialogue on agriculture, urging policy re-orientation despite subsidies, to address challenges like soil degradation and environmental pollution.
Jul 22, 2024 13:56
India Remittances...
India Remittances to Grow 3.7% in 2024 to $124 Billion: Eco Survey
India's remittances, a key source of external financing, are projected to rise to $124 billion in 2024, driven by strong labor markets and diversification of migrant workforce.
Jul 22, 2024 13:52

More Top News »

Report Card

PE Ratios
29.38
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 3 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 4 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Hi sir, please advice whether my current monthly...

Hi , I am a lecture in Engg college with 50k salary...

I am 50 year old retired person.I have fd of 2 cr...

I have invested 10L in Mutual Fund through Lumpsum...

Hi, I want to understand about SWP mutual fund...

Sir My age is 53. My PF contribution from salary is...

More REDIFFGURUS

RediffGurus

Money question

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close